Skip to main content
Log in

The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators

  • Original Articles
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

In the present study, we demonstrated the inhibitory effect of magnolol on the plasma leakage in passive cutaneous anaphylactic (PCA) reaction, neurogenic inflammation, dorsal skin and ear edema in mice. Hind-paw skin plasma extravasation caused by antidromic stimulation of the saphenous nerve was reduced in mice pretreated with magnolol, diphenydramine or methysergide, but not with indomethacin. Ear edema formation in the PCA reaction was reduced by magnolol in dose-dependent manner. In addition, histamine-, serotonin-, compound 48/80-, bradykinin- and substance P-induced ear edema in mice was also suppressed by magnolol. A dose- and time-dependency of the inhibitory effect of magnolol was demonstrated in histamine- and compound 48/80-induced dorsal skin edema. The maximal inhibitory effect produced by a single dose of magnolol (10 mg/kg) persisted for 1 h, and significant suppression lasted for at least 3 h. In compound 48/80-pretreated mice, the histamine content of the ear was greatly reduced. Bradykinin- and substance P-induced ear edema in compound 48/80-pretreated mice was less severe than that seen in normal mice, but was still significantly reduced by magnolol pretreatment. Moreover, the inhibitory effect of magnolol was more marked than that of diphenhydramine combined with methysergide. These results suggest that the inhibitory effect of magnolol on local edema formation probably occurs through a nonselective inhibition on vascular tissue to prevent the permeability change caused by various mediators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barrett AJ (1972) Lysosomes, In: Dingle JT (ed) A laboratory handbook. Elsevier, Amsterdam, pp 118–120

    Google Scholar 

  • Dobbins DE, Soika CY, Premen AJ, Grega GJ, Dobney JM (1982) Blockade of histamine and bradykinin-induced increases in lymph flow, protein concentration and protein transport by terbutaline in vivo. Microcirc 2:127–150

    Google Scholar 

  • Florjanc-Irman T, Erjavec F (1983) Compound 48/80 and substance P induced release of histamine and serotonin from rat peritoneal mast cells. Agents Actions 13:138–141

    Google Scholar 

  • Foreman JC, Jordan CC (1984) Neurogenic inflammation. Trends Pharmacol Sci 5:116–119

    Google Scholar 

  • Fujita M, Itokawa H, Sashida Y (1972) Honokiol, a new phenolic compound isolated from the bark of Magnolia obovata Thunb. Chem Pharm Bull 20:212–213

    Google Scholar 

  • Gabbiani G, Badonnel MC, Majno G (1970) Intra-arterial injections of histamine, serotonin, or bradykinin: A tropographic sutdy of vascular leakage. Proc Soc Exp Biol NY 135:447–452

    Google Scholar 

  • Gamse R, Holzer P, Lembeck F (1980) Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 68:207–213

    Google Scholar 

  • Garrison JC (1991) Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 575–599

    Google Scholar 

  • Haddy FJ, Scott JB, Grega GJ (1976) Peripheral circulation: fluid transfer across the microvascular mechanism. In Guyton AG, Cowley AW, Jr (eds) Cardiovascular physiology II. Park Press, Baltimore, MD, pp 63–110

    Google Scholar 

  • Håkanson R, Rönnberg AL (1974) Improved fluorometric assay of histamine. Anal Biochem 60:560–567

    Google Scholar 

  • Hanahae THP (1984) Mechanism of histamine release from rat isolated peritoneal mast cells by dextran: the role of immunoglobulin E. Agents Actions 14:468–474

    Google Scholar 

  • Heltianu C, Simionescu M, Simionescu N (1982) Histamine receptor of the microvascular endothelium revealed in situ with a histamine-ferritin conjugated: characteristic high-affinity binding sites in venules. J Cell Biol 93:357–364

    Google Scholar 

  • Ialenti A, Ianaro A, Moncada S, Di Rosa M (1992) Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177–182

    Google Scholar 

  • Insel PA (1990) Analgesic-antipyretic and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 638–681

    Google Scholar 

  • Ito K, Iida T, Ichino K, Tsunezuka M, Mattori M, Namba T (1982) Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull 30:3347–3353

    Google Scholar 

  • Iwamoto I, Nadel JA (1989) Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin. Life Sci 44:1089–1095

    Google Scholar 

  • Jancsó N, Jancsó-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31:138–151

    Google Scholar 

  • Katayama S, Shionoya H, Ohtake S (1978) A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 22:89–101

    Google Scholar 

  • Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 310:175–183

    Google Scholar 

  • Lembeck F, Donnerer J, Barthó L (1982) Inhibition of neurogenic vasodilatation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Eur J Pharmacol 85:171–176

    Google Scholar 

  • Lewis GP (1970) Kinins in inflammatory and tissue injury. Handb Exp Pharmak 25:516–530

    Google Scholar 

  • Lewis T, Marvin HM (1927) Observations relating to vasodilatation arising from antidromic impulses, to herpes zoster and trophic effect. Heart 14:27–46

    Google Scholar 

  • Majno G, Palade GE (1961) Studies on inflammation I. The effect of histamine and serotonin on vascular permeability. J Biophys Biochem Cytol 11:571–605

    Google Scholar 

  • Maling HM, Webster ME, Williams MA, Saul W, Anderson W Jr (1974) Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: antagonists and mechanism of action. J Pharmacol Exp Ther 191:300–310

    Google Scholar 

  • Marceau F, Knap M, Regoli D (1981) Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin. Can J Physiol Pharmacol 59:921–926

    Google Scholar 

  • McClain DE, Donlon MA, Chock S, Catravas GN (1983) The effect of calmodulin on histamine release in the rat peritoneal mast cell. Biochem Biophys Acta 763:419–425

    Google Scholar 

  • Moran NC, Uvnäs B, Westerholm B (1962) Release of 5-hydroxytryptamine and histamine from rat mast cells. Acta Physiol Scand 56:26–41

    Google Scholar 

  • Morgan-Boyd R, Stewart JM, Vavrek RJ, Hassid A (1987) Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells. Am J Physiol 253:C588-C598

    Google Scholar 

  • Northover AM (1990) Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vivo. Agents Actions 29:184–188

    Google Scholar 

  • Owen DAA, Pipkin MA, Woodward DF (1984) Studies on cutaneous vascular permeability in the rat: increases caused by histamine and histamine-like agents. Agents Actions 14:39–42

    Google Scholar 

  • Paton WDM (1951) Compound 48/80, a potent histamine liberator. Br J Pharmacol 6:499–508

    Google Scholar 

  • Perper RJ, Qronsky AL, Blamcuzzi U (1975) An analysis of the specificity in pharmacological inhibition of the passive cutaneous anaphylaxis reaction in mice and rats. J Pharmacol Exp Ther 193:594–602

    Google Scholar 

  • Saria A, Lundberg JM, Skofitsch G, Lembeck F (1983) Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol 324:212–218

    Google Scholar 

  • Saria S, Hua X, Skofitsch G, Lundberg JM (1984) Inhibition of compound 48/80-induced vascular protein leakage by pretreatment with capsaicin and a substance P antagonist. Naunyn Schmiedebergs Arch Pharmacol 328:9–15

    Google Scholar 

  • Shore PA, Burkhalter A, Cohen VH Jr (1959) A method for the fluorometric assay of histamine in tissue. J Pharmacol Exp Ther 127:182–186

    Google Scholar 

  • Sjoerdsma A, Wualkes TP, Weissbach H (1957) Serotonin and histamine in mast cells. Science 125:1202–1203

    Google Scholar 

  • Sullivan TJ, Parker CW (1979) Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. J Immunol 122:431–436

    Google Scholar 

  • Svensjo E, Persson CGA, Rutili G (1977) Inhibition of bradykinin induced macromolecular leakage from post-capillary venules by a β2-adrenoceptor stimulant, terbutaline. Acta Physiol Scand 101: 504–506

    Google Scholar 

  • Svensjo E, Sharp D, Arfors KE (1973) Leakage induced by histamine in postcapillary venules on the hamster check pouch. Microvasc Res 6:261

    Google Scholar 

  • Taira M, Kohno SW, Yamamura H, Ohata K (1988) Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. Agents Actions 24:189–195

    Google Scholar 

  • Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen VP, Hsu HY (1988) Two antiplatelet agents from Magnolia officinalis. Thromb Res 50:757–765

    Google Scholar 

  • Teng CM, Yu SM, Chen CC, Huang YL, Huang TF (1990) EDRF-release and Ca++-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci 47:1153–1161

    Google Scholar 

  • Teng CM, Ko FN, Wang JP, Lin CN, Wu TS, Chen CC, Huang TF (1991) Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J Pharm Pharmacol 43:667–669

    Google Scholar 

  • Tsurufuji S, Sugio K, Takemasa F (1979) The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280:408–410

    Google Scholar 

  • Wang JP, Hsu MF, Ouyang C, Teng CM (1989) Edematous response caused by [Thi5,8, D-Phe7] bradykinin, a B2 receptor antagonist, is due to mast cell degranulation. Eur J Pharmacol 161:143–149

    Google Scholar 

  • Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS, Teng CM (1992) Antiinflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol 346:707–712

    Google Scholar 

  • Watanabe K, Watanabe H, Goto Y, Yamamoto N, Yoshizaki M (1975) Studies on the active principles of magnolia bark: centrally acting muscle relaxant activity of magnolol and honokiol. Jpn J Pharmacol 25:605–607

    Google Scholar 

  • Waynforth HB (1980) Specific surgical operations. In: Waynforth HB (ed) Experimental and surgical technique in the rat. Acedemic Press, London, pp 124–208

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: J.-P. Wang at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, JP., Raung, SL., Chen, CC. et al. The inhibitory effect of magnolol on cutaneous permeability in mice is probably mediated by a nonselective vascular hyporeactivity to mediators. Naunyn-Schmiedeberg's Arch Pharmacol 348, 663–669 (1993). https://doi.org/10.1007/BF00167245

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167245

Key words

Navigation